{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:47:54Z","timestamp":1789706874098,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T00:00:00Z","timestamp":1421366400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13722-014-0023-0","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T16:03:15Z","timestamp":1421337795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder"],"prefix":"10.1186","volume":"10","author":[{"given":"Aaron D","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeronimo","family":"Maradiaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L","family":"Starrels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo O","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,16]]},"reference":[{"key":"23_CR1","volume-title":"Correctional populations in the United States, 2011","author":"LE Glaze","year":"2012","unstructured":"Glaze LE, Parks E. Correctional populations in the United States, 2011. Washington DC: U.S. Department of Justice; 2012."},{"key":"23_CR2","volume-title":"Drug use and dependence, state and federal prisoners, 2004 (revised 1\/19\/07)","author":"CJ Mumola","year":"2006","unstructured":"Mumola CJ, Karberg JC. Drug use and dependence, state and federal prisoners, 2004 (revised 1\/19\/07). Washington, DC: U.S. Department of Justice; 2006."},{"key":"23_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(10)61053-7","volume":"377","author":"S Fazel","year":"2011","unstructured":"Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011;377:956\u201365.","journal-title":"Lancet"},{"key":"23_CR4","volume-title":"Substance dependence, abuse, and treatment of jail inmates, 2002","author":"JC Karberg","year":"2005","unstructured":"Karberg JC, James DJ. Substance dependence, abuse, and treatment of jail inmates, 2002. Washington DC: U.S. Department of Justice; 2005."},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5055\/jom.2007.0021","volume":"3","author":"AE Boutwell","year":"2007","unstructured":"Boutwell AE, Nijhawan A, Zaller N, Rich JD. Arrested on heroin: a national opportunity. J Opioid Manag. 2007;3:328\u201332.","journal-title":"J Opioid Manag"},{"key":"23_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2008.976","volume":"301","author":"RK Chandler","year":"2009","unstructured":"Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301:183\u201390.","journal-title":"JAMA"},{"key":"23_CR7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","volume":"103","author":"MS Gordon","year":"2008","unstructured":"Gordon MS, Kinlock TW, Schwartz RP, O\u2019Grady KE. A randomized clinical trial of methadone maintenance for prisoners: findings at 6\u00a0months post-release. Addiction. 2008;103:1333\u201342.","journal-title":"Addiction"},{"key":"23_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159:592\u2013600.","journal-title":"Ann Intern Med"},{"key":"23_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison\u2013a high risk of death for former inmates. N Engl J Med. 2007;356:157\u201365.","journal-title":"N Engl J Med"},{"key":"23_CR10","doi-asserted-by":"crossref","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008;(2):CD002207.","DOI":"10.1002\/14651858.CD002207.pub3"},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","volume":"93","author":"LA Marsch","year":"1998","unstructured":"Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515\u201332.","journal-title":"Addiction"},{"key":"23_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","volume":"105","author":"A Nunn","year":"2009","unstructured":"Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105:83\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"23_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jurban\/jti072","volume":"82","author":"JD Rich","year":"2005","unstructured":"Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005;82:411\u20139.","journal-title":"J Urban Health"},{"key":"23_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08897077.2011.616797","volume":"33","author":"JD Lee","year":"2012","unstructured":"Lee JD, Rich JD. Opioid pharmacotherapy in criminal justice settings: now is the time. Subst Abus. 2012;33:1\u20134.","journal-title":"Subst Abus"},{"key":"23_CR15","volume-title":"Treatment behind bars: substance abuse treatment in New York prisons, 2007\u20132010","author":"The Correctional Association of New York","year":"2011","unstructured":"The Correctional Association of New York. Treatment behind bars: substance abuse treatment in New York prisons, 2007\u20132010. New York: The Correctional Association of New York; 2011."},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/16066350500151739","volume":"13","author":"AH Simpler","year":"2005","unstructured":"Simpler AH, Langhinrichsen-Rohling J. Substance use in prison: how much occurs and is it associated with psychopathology? Addiction Research & Theory. 2005;13:503\u201311.","journal-title":"Addiction Research & Theory"},{"key":"23_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/bsl.2370090303","volume":"9","author":"DJ Nurco","year":"1991","unstructured":"Nurco DJ, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behav Sci Law. 1991;9:221\u201342.","journal-title":"Behav Sci Law"},{"key":"23_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/0011128705281755","volume":"52","author":"S Belenko","year":"2006","unstructured":"Belenko S. Assessing released inmates for substance-abuse-related service needs. Crime & Delinquency. 2006;52:94\u2013113.","journal-title":"Crime & Delinquency"},{"key":"23_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1360-0443.2005.01050.x","volume":"100","author":"KA Dolan","year":"2005","unstructured":"Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 2005;100:820\u20138.","journal-title":"Addiction"},{"key":"23_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/ADM.0b013e31814b8880","volume":"1","author":"CA Garcia","year":"2007","unstructured":"Garcia CA, Correa GC, Viver AD, Kinlock TW, Gordon MS, Avila CA, et al. Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. J Addict Med. 2007;1:126\u201332.","journal-title":"J Addict Med"},{"key":"23_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0093854807309111","volume":"35","author":"TW Kinlock","year":"2008","unstructured":"Kinlock TW, Gordon MS, Schwartz RP, O\u2019Grady KE. A study of methadone maintenance for male prisoners: 3-month postrelease outcomes. Crim Justice Behav. 2008;35:34\u201347.","journal-title":"Crim Justice Behav"},{"key":"23_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","volume":"99","author":"S Magura","year":"2009","unstructured":"Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, et al. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend. 2009;99:222\u201330.","journal-title":"Drug Alcohol Depend"},{"key":"23_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","volume":"142","author":"MS Gordon","year":"2014","unstructured":"Gordon MS, Kinlock TW, Schwartz RP, Fitzgerald TT, O\u2019Grady KE, Vocci FJ. A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry. Drug Alcohol Depend. 2014;142:33\u201340.","journal-title":"Drug Alcohol Depend"},{"key":"23_CR24","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/j.1360-0443.2008.02361.x","volume":"103","author":"GP McMillan","year":"2008","unstructured":"McMillan GP, Lapham S, Lackey M. The effect of a jail methadone maintenance therapy (MMT) program on imate recidivism. Addiction. 2008;103:2017\u201323.","journal-title":"Addiction"},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/002204269302300106","volume":"23","author":"S Magura","year":"1993","unstructured":"Magura S, Rosenblum A, Lewis C, Joseph H. Effectiveness of in-jail methadone maintenance. J Drug Issues. 1993;23:75\u201399.","journal-title":"J Drug Issues"},{"key":"23_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11524-006-9047-4","volume":"83","author":"J Olphen van","year":"2006","unstructured":"van Olphen J, Freudenberg N, Fortin P, Galea S. Community reentry: perceptions of people with substance use problems returning home from New York City jails. J Urban Health. 2006;83:372\u201381.","journal-title":"J Urban Health"},{"key":"23_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1940-0640-7-3","volume":"7","author":"IA Binswanger","year":"2012","unstructured":"Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7:3.","journal-title":"Addict Sci Clin Pract"},{"key":"23_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijlp.2011.07.002","volume":"34","author":"IA Binswanger","year":"2011","unstructured":"Binswanger IA, Nowels C, Corsi KF, Long J, Booth RE, Kutner J, et al. \u201cFrom the prison door right to the sidewalk, everything went downhill\u201d, a qualitative study of the health experiences of recently released inmates. Int J Law Psychiatry. 2011;34:249\u201355.","journal-title":"Int J Law Psychiatry"},{"key":"23_CR29","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S0376-8716(03)00057-7","volume":"70","author":"J Mendelson","year":"2003","unstructured":"Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug Alcohol Depend. 2003;70:S29\u201337.","journal-title":"Drug Alcohol Depend"},{"key":"23_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10509670903534951","volume":"49","author":"TW Kinlock","year":"2010","unstructured":"Kinlock TW, Gorden MS, Schwartz RP, Fitzgerald TT. Developing and implementing a new prison-based buprenorphine treatment program. J Offender Rehabil. 2010;49:91\u2013109.","journal-title":"J Offender Rehabil"},{"key":"23_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1056\/NEJMoa022164","volume":"349","author":"PJ Fudala","year":"2003","unstructured":"Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949\u201358.","journal-title":"N Engl J Med"},{"key":"23_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","volume":"39","author":"CL Arfken","year":"2010","unstructured":"Arfken CL, Johanson CE, di Menza S, Schuster CR. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians. J Subst Abuse Treat. 2010;39:96\u2013104.","journal-title":"J Subst Abuse Treat"},{"key":"23_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/ADM.0b013e3180473c11","volume":"1","author":"DA Fiellin","year":"2007","unstructured":"Fiellin DA. The first three years of buprenorphine in the United States: experience to date and future directions. J Addict Med. 2007;1:62\u20137.","journal-title":"J Addict Med"},{"key":"23_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0306-4603(93)90036-9","volume":"18","author":"JA Cunningham","year":"1993","unstructured":"Cunningham JA, Sobell LC, Sobell MB, Agrawal S, Toneatto T. Barriers to treatment: why alcohol and drug abusers delay or never seek treatment. Addict Behav. 1993;18:347\u201353.","journal-title":"Addict Behav"},{"key":"23_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/ADM.0b013e3181cc9610","volume":"4","author":"PT Korthuis","year":"2010","unstructured":"Korthuis PT, Gregg J, Rogers WE, McCarty D, Nicolaidis C, Boverman J. Patients\u2019 reasons for choosing office-based buprenorphine: preference for patient-centered care. J Addict Med. 2010;4:204\u201310.","journal-title":"J Addict Med"},{"key":"23_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/02791072.2010.10400696","volume":"42","author":"E Awgu","year":"2010","unstructured":"Awgu E, Magura S, Rosenblum A. Heroin-dependent inmates\u2019 experiences with buprenorphine or methadone maintenance. J Psychoactive Drugs. 2010;42:339\u201346.","journal-title":"J Psychoactive Drugs"},{"key":"23_CR37","first-page":"500","volume":"40","author":"C Cunningham","year":"2008","unstructured":"Cunningham C, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil R, et al. Buprenorphine treatment in an urban community health center: what to expect. Fam Med. 2008;40:500\u20136.","journal-title":"Fam Med"},{"key":"23_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1353\/hpu.2014.0039","volume":"25","author":"AD Fox","year":"2014","unstructured":"Fox AD, Anderson MR, Bartlett G, Valverde J, MacDonald RF, Shapiro LI, et al. A description of an urban transitions clinic serving formerly incarcerated persons. J Health Care Poor Underserved. 2014;25:376\u201382.","journal-title":"J Health Care Poor Underserved"},{"key":"23_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1090198104263660","volume":"31","author":"A Bandura","year":"2004","unstructured":"Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31:143\u201364.","journal-title":"Health Educ Behav"},{"key":"23_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/08897077.2013.804484","volume":"35","author":"AD Fox","year":"2014","unstructured":"Fox AD, Shah PA, Sohler NL, Lopez CM, Starrels JL, Cunningham CO. I heard about it from a friend: assessing interest in buprenorphine treatment. Subst Abus. 2014;35:74\u20139.","journal-title":"Subst Abus"},{"key":"23_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5055\/jom.2013.0183","volume":"9","author":"PA Shah","year":"2013","unstructured":"Shah PA, Sohler NL, Lopez C, Fox AD, Cunningham CO. Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program. J Opioid Manag. 2013;9:407\u201313.","journal-title":"J Opioid Manag"},{"key":"23_CR42","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.addbeh.2011.01.032","volume":"36","author":"PM Roman","year":"2011","unstructured":"Roman PM, Abraham AJ, Knudsen HK. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict Behav. 2011;36:584\u20139.","journal-title":"Addict Behav"},{"key":"23_CR43","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jama.2014.2147","volume":"311","author":"Y Olsen","year":"2014","unstructured":"Olsen Y, Sharfstein JM. Confronting the stigma of opioid use disorder\u2013and its treatment. JAMA. 2014;311:1393\u20134.","journal-title":"JAMA"},{"key":"23_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/02791072.2009.10399907","volume":"41","author":"SG Mitchell","year":"2009","unstructured":"Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, et al. Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users. J Psychoactive Drugs. 2009;41:145\u201352.","journal-title":"J Psychoactive Drugs"},{"key":"23_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","volume":"63","author":"SD Comer","year":"2006","unstructured":"Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2006;63:210\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"23_CR46","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/add.12208","volume":"108","author":"E Krupitsky","year":"2013","unstructured":"Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness. Addiction. 2013;108:1628\u201337.","journal-title":"Addiction"},{"key":"23_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.drugalcdep.2005.02.009","volume":"79","author":"GK Hulse","year":"2005","unstructured":"Hulse GK, Tait RJ, Comer SD, Sullivan MA, Jacobs IG, Arnold-Reed D. Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug Alcohol Depend. 2005;79:351\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"23_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jsat.2007.08.014","volume":"35","author":"RJ Tait","year":"2008","unstructured":"Tait RJ, Ngo HT, Hulse GK. Mortality in heroin users 3\u00a0years after naltrexone implant or methadone maintenance treatment. J Subst Abuse Treat. 2008;35:116\u201324.","journal-title":"J Subst Abuse Treat"},{"key":"23_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/08897077.2011.609438","volume":"33","author":"DM Coviello","year":"2012","unstructured":"Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, et al. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus. 2012;33:48\u201359.","journal-title":"Subst Abus"}],"container-title":["Addiction Science & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-014-0023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13722-014-0023-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-014-0023-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-014-0023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:42:46Z","timestamp":1553640166000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-014-0023-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,16]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1186\/s13722-014-0023-0","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,16]]},"assertion":[{"value":"27 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}